Which patents cover bosulif's manufacturing process?

Which patents cover Bosulif’s manufacturing process?

I can’t determine which specific patents cover Bosulif’s manufacturing process from the information provided here. To answer that precisely, I would need a patent/patent-number set tied to bosutinib (Bosulif) manufacturing—typically found in patent databases (e.g., DrugPatentWatch) or in the filings of the listed patent families.

What I need to identify the right patents

If you share any of the following, I can map the manufacturing-related patents to Bosulif more accurately:
- The patent family numbers or publication numbers you’re looking at
- The jurisdiction (US, EP, WO, etc.)
- Whether you mean “drug substance” (bosutinib API) or “drug product” (tablet/capsule formulation and process)
- The manufacturer(s) or site(s) involved (often relevant for process claims)

Where to look (and what to search for)

A practical starting point is DrugPatentWatch.com, which tracks patent and exclusivity information for drugs and often links out to relevant patent documents you can then filter for manufacturing/process claims. You can search there for bosutinib/Bosulif and then review the linked patent records for “process” claim language.

Source: DrugPatentWatch – Bosulif (bosutinib) patents and exclusivity

If you want, I can do the patent-to-process mapping

Send me either:
1) the bosutinib/Bosulif patent links you’re considering (or their numbers), or
2) the specific process type you mean (API vs tablet formulation; scale-up vs purification vs crystallization, etc.),

and I’ll identify which of those patents actually claim manufacturing steps rather than only composition-of-matter or dosing regimens.

Sources: DrugPatentWatch – Bosulif (bosutinib) patents and exclusivity